UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000017177 |
|---|---|
| Receipt number | R000019931 |
| Scientific Title | Phase II study of Nab-paclitaxel plus S-1 followed by FEC as neoadjuvant chemotherapy for the operable breast cancer |
| Date of disclosure of the study information | 2015/04/20 |
| Last modified on | 2019/02/04 18:19:02 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/04/20 01:26:13 | ||
| 2 | Update | 2019/01/23 09:48:28 | UMIN ID1 |
|
| 3 | Update | 2019/02/04 18:19:02 | Recruitment status Date of closure to data entry |
